Strategies for Maximising Survival: Advances in High-Risk* Acute Myeloid Leukaemia (AML)

This Continuing Professional Development (CPD) accredited webinar gives an overview of the current AML landscape and provides insights from evidence-based practice on managing patients with AML.

Prescribing information can be found at the top of this page. Adverse event reporting is available at the bottom of this page.

Topics: Ambulatory care AML Landscape Cytogenetics Vyxeos Liposomal Data


Adverse events should be reported. Reporting forms and information for the UK can be found at

For Ireland, reporting forms and information can be found at:

Adverse events should also be reported to Jazz Pharmaceuticals at

UK-VYX-2100054 | May 2021